ANI Pharmaceuticals (NASDAQ:ANIP) Receives Neutral Rating fr

ANI Pharmaceuticals (NASDAQ:ANIP – Get Rating)‘s stock had its “neutral” rating restated by research analysts at Cantor Fitzgerald in a report released on Wednesday, Zacks.com reports. Other research analysts have also recently issued research reports about the stock. Zacks Investment Research upgraded shares of ANI Pharmaceuticals from a “sell” rating to a “hold” rating in […]

Related Keywords

Raymond James , Jeanne Thoma , Thompson Siegel Walmsley , Zacks Investment Research , Blackrock Inc , Pharmaceuticals Company Profile Get Rating , Cantor Fitzgerald , William Blair Investment Management , Pharmaceuticals Inc , Dimensional Fund Advisors , Ani Pharmaceuticals , Get Rating , Investment Research , Director Jeanne Thoma , Blair Investment Management , Street Corp , Fund Advisors , Company Profile , Nasdaq Anip , Manip , Medical , Reiterated Rating ,